USE OF BOSWELLIA ACIDS AND SYNTHETIC BOSWELLIA ACID DERIVATIVES FOR INHIBITING MICROSOMAL PROSTANGLANDIN E2 SYNTHASE AND CATHEPSIN G

摘要

The present invention relates to new boswellia acid derivatives. The present invention furthermore relates to the use of preparations with boswellia acid derivatives or synthetic derivatives, especially with boswellia acid derivatives, which are esterified or etherified at the C3-OH function, for inhibiting the induceable microsomal prostaglandin E2 synthase-1 and/or for inhibiting cathepsin G. Furthermore, the invention relates to the use of boswellia acids or synthetic derivatives for the preparation of a drug for the treatment of PGE2-and/or cathepsin G-induced pathological conditions.